Glenmark sells gynac business for Rs 115 crore

The sale of the gynac business comes two years after it sold its orthopedic business to the same company. Integrace will pay Rs 115 crore for four products of the portfolio that includes products like Dubagest, Mumfer and Fenza. These three products currently have sales of Rs 60 crore and are growing by 15%.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news